Clinical trial
Smoking Treatment of Prisoners
NCT00110630 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00110630 |
|---|---|
| Title | Smoking Treatment of Prisoners |
| Official title | Smoking Treatment of Prisoners: Project "STOP" |
| Acronym | STOP |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tobacco Use Cessation, Tobacco Use Disorder |
| Intervention type | Behavioral |
| Interventions | 10-week smoking cessation group therapy combined with NicoDerm CQ |
| Enrollment | 250 |
| Start date | Jun 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | May 11, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: